Metabolic syndrome: What's in a name?

Wisconsin Medical Journal

Volumn 105, Issue 5, 2006, Pages 17-20

  Wubben, Deborah P ^a,b,c   Adams, Alexandra K ^a,b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b Department of Medicine ^*

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN;

ADIPOSE TISSUE; CARDIOVASCULAR RISK; CONSENSUS; DYSLIPIDEMIA; FAMILY HISTORY; HEALTH PROGRAM; HUMAN; HYPERINSULINEMIA; HYPERTENSION; INSULIN RESISTANCE; LIFESTYLE; MEDICAL SOCIETY; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOGENESIS; PHYSICAL ACTIVITY; PHYSICIAN; PRIMARY MEDICAL CARE; REVIEW; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SMOKING; WAIST CIRCUMFERENCE; WORLD HEALTH ORGANIZATION;

CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; HUMANS; INFLAMMATION; INSULIN RESISTANCE; METABOLIC SYNDROME X; OBESITY; PROGNOSIS; RISK FACTORS; TERMINOLOGY; WORLD HEALTH ORGANIZATION;

EID: 33747140450     PISSN: 10981861     EISSN: 10981861     Source Type: Journal    
DOI: None     Document Type: Review

References (20)

1. Expert Panel on Detection EaToHBCiA. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486-2497.
2. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/ National Heart, Lung, and Blood Institute scientific statement. Circulation. 2005;112(17):2735-2752.
3. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005;365(9468):1415-1428.
4. Grundy SM. Does the metabolic syndrome exist? Diabetes Care. 2006;29(7):1689-1692.
5. Kahn R, Buse J, Ferrannini E, Stern M. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2005;28(9):2289-2304.
6. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications, part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15(7):539-553.
7. Alberti KG, Zimmet P, Shaw J. The metabolic syndrome - a new worldwide definition. Lancet. 2005;366(9491):1059-1062.
8. The Expert Committee on the Diagnosis and Classification of Diabetes M. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care. 2003;26(11):3160-3167.
9. Cheal KL, Abbasi F, Lamendola C, McLaughlin T, Reaven GM, Ford ES. Relationship to insulin resistance of the Adult Treatment Panel III diagnostic criteria for identification of the metabolic syndrome. Diabetes. 2004;53(5):1195-1200.
10. McLaughlin T, Abbasi F, Cheal K, Chu J, Lamendola C, Reaven G. Use of metabolic markers to identify overweight individuals who are insulin resistant. Ann Intern Med. 2003;139(10):802-809.
11. Liao Y, Kwon S, Shaughnessy S, et al. Critical evaluation of Adult Treatment Panel III criteria in identifying insulin resistance with dyslipidemia. Diabetes Care. 2004;27(4):978-983.
12. Stern SE, Williams K, Ferrannini E, DeFronzo RA, Bogardus C, Stern MP. Identification of individuals with insulin resistance using routine clinical measurements. Diabetes. 2005;54(2):333-339.
13. Stern MP, Williams K, Gonzalez-Villalpando C, Hunt KJ, Haffner SM. Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease? Diabetes Care. 2004;27(11):2676-2681.
14. Kahn R, Buse J, Ferrannini E, Stern M. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes: response to Citrome et al, Giugliano and Esposito, Cheta, and Psaty et al. Diabetes Care. 2006;29(1):177-178.
15. Giugliano D, Esposito K. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes: response to Kahn et al. Diabetes Care. 2006;29(1):175-176.
16. Diabetes Prevention Program Research G. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393-403.
17. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42(6):1206-1252.
18. Force* USPST. Screening for obesity in adults: recommendations and rationale. Ann Intern Med. 2003;139(11):930-932.
19. Berg AO, US Preventive services task force. Behavioral counseling in primary care to promote physical activity: recommendation and rationale. Am J Nurs. 2003;103(4):101-107; discussion 109.
20. Orchard TJ, Temprosa M, Goldberg R, et al. The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: The Diabetes Prevention Program randomized trial. Ann Intern Med. 2005;142(8):611-619.